Literature DB >> 2001424

Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide.

J D Bell1, J A Lee, H A Lee, P J Sadler, D R Wilkie, R H Woodham.   

Abstract

We have used 1H-, 13C- and 14N-NMR spectroscopy to investigate the constituents of plasma and urine in 16 patients with chronic renal failure (CRF). Resonances not previously observed in spectra of plasma from healthy volunteers were seen in CRF plasma, including those for trimethylamine-N-oxide (TMAO) and dimethylamine (DMA). A possible analogy with the plasma of elasmobranch fishes, in which TMAO stabilizes proteins in the presence of very high urea concentrations, is noted. The intensity of the TMAO resonance for CRF subjects was correlated with the plasma concentration of urea (R = 0.55) and creatinine (R = 0.74), suggesting that the presence of TMAO is closely related to the degree of renal failure. When normal subjects ate a meal of TMAO-containing fish, TMAO appeared rapidly in the plasma and in the urine. Thus TMAO is efficiently cleared by the healthy kidney. Differences in the interaction of lactate with plasma proteins were detected by NMR, suggesting that uraemia impairs their transport roles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001424     DOI: 10.1016/0925-4439(91)90046-c

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Cyanate is a novel inducer of endothelial icam-1 expression.

Authors:  Dalia El-Gamal; Michael Holzer; Martin Gauster; Rudolf Schicho; Veronika Binder; Viktoria Konya; Christian Wadsack; Rufina Schuligoi; Akos Heinemann; Gunther Marsche
Journal:  Antioxid Redox Signal       Date:  2011-10-14       Impact factor: 8.401

2.  Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD.

Authors:  W H Wilson Tang
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

Review 3.  Analytical approaches to metabolomics and applications to systems biology.

Authors:  Jeffrey H Wang; Jaeman Byun; Subramaniam Pennathur
Journal:  Semin Nephrol       Date:  2010-09       Impact factor: 5.299

4.  Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model.

Authors:  Munsoor A Hanifa; Martin Skott; Raluca G Maltesen; Bodil S Rasmussen; Søren Nielsen; Jørgen Frøkiær; Troels Ring; Reinhard Wimmer
Journal:  Metabolomics       Date:  2019-08-17       Impact factor: 4.290

Review 5.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

Review 6.  Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  J Card Fail       Date:  2015-10-03       Impact factor: 5.712

7.  Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.

Authors:  Fei Guo; Qing Dai; Xiangchang Zeng; Yan Liu; Zhirong Tan; Hao Zhang; Dongsheng Ouyang
Journal:  Int Urol Nephrol       Date:  2020-09-18       Impact factor: 2.370

8.  Trimethylamine-N-oxide acutely increases cardiac muscle contractility.

Authors:  Carlee I Oakley; Julian A Vallejo; Derek Wang; Mark A Gray; LeAnn M Tiede-Lewis; Tilitha Shawgo; Emmanuel Daon; George Zorn; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-03       Impact factor: 4.733

9.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 10.  Microbiome, trimethylamine N-oxide, and cardiometabolic disease.

Authors:  W H Wilson Tang; Stanley L Hazen
Journal:  Transl Res       Date:  2016-07-18       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.